Kinetic Profile of the Transcriptome Changes Induced in the Choroid Plexus by Peripheral Inflammation
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The choroid plexus, being part of the blood-brain barriers and responsible for the production of cerebrospinal fluid, is ideally positioned to transmit signals into and out of the brain. This study, using microarray analysis, shows that the mouse choroid plexus displays an acute-phase response after an inflammatory stimulus induced in the periphery by lipopolysaccharide (LPS). Remarkably, the response is specific to a restricted number of genes (out of a total of 24,000 genes analyzed, 252 are up-regulated and 173 are down-regulated) and transient, as it returns to basal conditions within 72 h. The up-regulated genes cluster into families implicated in immune-mediated cascades and in extracellular matrix remodeling, whereas those down-regulated participate in maintenance of the barrier function. Importantly, several acute-phase proteins, whose blood concentrations rise in response to inflammation, may contribute to the effects observed in vivo after LPS injection, as suggested by the differential response of primary choroid plexus epithelial cell cultures to LPS alone or to serum collected from animals exposed to LPS. By modulating the composition of the cerebrospinal fluid, which will ultimately influence the brain parenchyma, the choroid plexus response to inflammation may be of relevance in brain homeostasis in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 3×
“Notably, the kinetics of the CP response proved to be similar to that of the liver (Ceciliani et al, 2002; Gabay and Kushner, 1999) in terms of response onset and shut-off; and in some of the acute-phase proteins secreted (e.”
BackgroundThe JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922 · cited 1×
“Changes in the functionality and integrity of the BBB are relevant to the pathogenesis of a variety of diseases of the CNS (e.g., HIV-1 encephalitis, Alzheimer disease, MS, Parkinson disease, ischemia, and tumors) (Persidsky et al, 2006).”
BackgroundLAFLAMME, N., & RIVEST, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0339com · Cited by 501 · cited 1×
“With respect to LPS signaling, we confirmed that the gene encoding for the Toll-like receptor 4 (Tlr4), the LPS cognate receptor, is expressed in the CP (Laflamme and Rivest, 2001; Chakravarty and Herkenham, 2005).”
BackgroundChakravarty, S., & Herkenham, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4268-04.2005 · Cited by 396
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284 · cited 4×
“Interestingly, TLR2 is not liganded by LPS.”
BackgroundInfluentialHughes, P. M., Botham, M. S., Frentzel, S., Mir, A., & Perry, V. H. (2002) · Glia · doi:10.1002/glia.10037 · Cited by 252 · cited 1×
“The nature of the proteins secreted by the CP may change in response to disease or specific stimuli, as shown here for CCL2 and IL-6, and in previous studies for various cytokines, carrier proteins, and iron-related proteins (Marques et al, 2007, 2008; Hughes et al, 2002; Thibeault et al, 2001).”
BackgroundQuan, N., Stern, E. L., Whiteside, M. B., & Herkenham, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00193-3 · Cited by 251 · cited 1×
“Among these are immune mediators such as interleukin IL-1b and TNF (Nadeau and Rivest, 1999; Quan et al, 1999), enzymes such as prostaglandin D2 synthase (Marques et al, 2007) and bacteriostatic proteins such as lipocalin 2 (LCN2) (Marques et al, 2008).”
BackgroundNadeau, S., & Rivest, S. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199901000-00008 · Cited by 142 · cited 6×
“Among these are immune mediators such as interleukin IL-1b and TNF (Nadeau and Rivest, 1999; Quan et al, 1999), enzymes such as prostaglandin D2 synthase (Marques et al, 2007) and bacteriostatic proteins such as lipocalin 2 (LCN2) (Marques et al, 2008).”
BackgroundInfluential
Cited by
The Meningeal Lymphatic System: A New Player in Neurophysiology
Da Mesquita, S., Fu, Z., & Kipnis, J. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.022 · Cited by 479
Ghersi-Egea, J.-F., Strazielle, N., Catala, M., Silva-Vargas, V., Doetsch, F., & Engelhardt, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1807-1 · Cited by 436
“Indeed, the choroid plexus transcriptome, proteome, and secretome are dynamic and rapidly change in response to external cues, such as inflammation [89, 155].”
BackgroundChoroid plexus: biology and pathology
Wolburg, H., & Paulus, W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0627-8 · Cited by 375
Choroid plexus and the blood–cerebrospinal fluid barrier in disease
Solár, P., Zamani, A., Kubíčková, L., Dubový, P., & Joukal, M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00196-2 · Cited by 365
Blood–brain-barriers in aging and in Alzheimer’s disease
Marques, F., Sousa, J. C., Sousa, N., & Palha, J. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-38 · Cited by 274
Self-citationIdentification of a choroid plexus vascular barrier closing during intestinal inflammation
Carloni, S., Bertocchi, A., Mancinelli, S., Bellini, M., Erreni, M., Borreca, A., Braga, D., Giugliano, S., Mozzarelli, A. M., Manganaro, D., et al. (2021) · Science · doi:10.1126/science.abc6108 · Cited by 268
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation
Schwartz, M., & Deczkowska, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.001 · Cited by 246
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Self-citationLipocalin-2 protects the brain during inflammatory conditions
Kang, S. S., Ren, Y., Liu, C.-C., Kurti, A., Baker, K. E., Bu, G., Asmann, Y., & Fryer, J. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.243 · Cited by 162
The choroid plexus—a multi-role player during infectious diseases of the CNS
Schwerk, C., Tenenbaum, T., Kim, K. S., & Schroten, H. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00080 · Cited by 147
Shipley, F. B., Dani, N., Xu, H., Deister, C., Cui, J., Head, J. P., Sadegh, C., Fame, R. M., Shannon, M. L., Flores, V. I., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.024 · Cited by 118
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108
“This treatment elicited the significant change of 570 transcripts with >2FC, which is comparable to the gene expression changes found by others in the brain after systemic endotoxin treatment (Marques et al. 2009; Marsh et al. 2009; Mastronardi et al. 2007; Perreau et al. 2007).”
ResultInterleukin-10: A Key Cytokine in Depression?
Roque, S., Correia-Neves, M., Mesquita, A. R., Palha, J. A., & Sousa, N. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/187894 · Cited by 89
Self-citation
Metadata
- Authors
- Marques, F., Sousa, J. C., Coppola, G., Falcao, A. M., Rodrigues, A. J., Geschwind, D. H., Sousa, N., Correia-Neves, M., & Palha, J. A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2009-02-25
- Volume
- 29
- Issue
- 5
- Pages
- 921-932
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2050025596
- Cited by
- 120
- References
- 9
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.